September 20, 2007
Cross Your Fingers: Tenofovir
HIV prevention drug could save millions
US researchers have identified a preventative measure against HIV that could dramatically reduce the number of new cases in high risk areas such as sub-Saharan Africa.
Tenofovir is an antiviral drug that is currently used in combination medications given to HIV patients.
Is is being trailed on HIV negative participants of groups who are considered at high risk of contracting the virus, including gay and bisexual men, sex workers and drug users.
. . .
While cautious of over-stating its effects, it is possible that one pill per day of Tenofovir, manufactured by California pharmaceuticals company Gilead Sciences under the brand name Viread, could keep millions of people healthy.
They found that the best-case scenario in sub-Saharan Africa could be a reduction of 30 million new cases of HIV over the course of a decade.
Filed under: HIV/AIDS
